Chugai Pharmaceutical Co. Ltd. - Net Income

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Net-Income" stands at 397.20 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of 111.21 Billion JPY for the item "Net Income" represents an increase of 14.47 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of 111.21 Billion JPY for the item "Net Income" represents an increase of 1.57 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of 397.20 Billion JPY for the item "Net Income" represents an increase of 0.43 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.65 percent compared to the value the year prior.
The 1 year change in percent is 2.65.
The 3 year change in percent is 7.12.
The 5 year change in percent is 96.06.
The 10 year change in percent is 574.40.

The Serie's long term average value is 168.91 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 135.15 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +1,027.36%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -3.17%.